Pharmaceuticals

COPD and Asthma Drugs Market by Disease (COPD and Asthma) by Medication Class (Combination Drugs, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics and Others) and by Geography (North America, Europe, Asia-Pacific, LAMEA) - Global Opportunity Analysis and Industry Forecasts, 2014-2022

  • ALL22851
  • 120 Pages
  • October 2016
  • Pharmaceuticals

Asthma is a chronic respiratory disease blocking the airways of the lungs because of the inflammation, mucus production, tighten of muscles. The general symptoms are coughing, wheezing, shortness of breath and/or chest tightness and majorly these symptoms are closely related to the physical activity. There are different types of asthma, exercise-induced bronchoconstriction(EIB), allergic asthma, occupational asthma, childhood asthma. Chronic Obstructive Pulmonary Disease (COPD) is also respiratory disease which causes obstructions and difficulty in breathing, the primary cause of COPD is tobacco smoking and chemical flumes, dust, air pollution are minor causes of the disease. Major symptoms are long lasting cough, mucus that comes out along with cough, shortness of breath.



The world COPD and asthma drugs market is expected to reach $50,359 million by 2022, growing at a CAGR of 3.7% from 2016 to 2022. Increase in prevalence of asthma and COPD, increase in world ageing population, technological advancement in the treatment of asthma and COPD, growth in initiatives implemented by the government and non-government associations for rise in health awareness play a pivotal role in the growth of the global COPD and asthma drug market. Stringent government regulatory requirement for the approval of COPD and asthma drug, patent expiry of branded hamper the market growth.



The world asthma and COPD drugs market is segmented based on disease and medication class and geography. On the basis of disease, the market is segmented into COPD and asthma. Based on medication class, the world asthma and COPD drug market is segmented into combination products, short acting beta agonists (SABA), long acting beta agonists (LABA), inhaled corticosteroids (ICS), leukotriene antagonists (LTA), anticholinergics and others. And geographically, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA.



Key benefits




  • The study provides an in-depth analysis of the asthma and COPD drug market with current trends and future estimations to elucidate the imminent investment pockets in the market.

  • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.

  • Extensive analysis of the asthma and COPD drug market, by medication class, helps in the treatment of asthma and COPD diseases.

  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

  • Key market players within the asthma and COPD drug market are profiled in this report and their strategies are analyzed thoroughly, which predicts the competitive outlook of global asthma and COPD drug market.

  • Key market segments

  • The world COPD and asthma drug market is segmented by medication class, disease and geography.



MARKET BY DISEASES




  • COPD

  • Asthma



MARKET BY MEDICATION CLASS




  • Combination Products


    • Seretide/Advair

    • Symbicort

    • Relvar/Breo Ellipta

    • Flutiform

    • Dulera

    • Others



  • Leukotriene Antagonists (LTA)

    • Singulair

    • Others



  • Inhaled Corticosteroids (ICS)

    • Qvar

    • Pulmicort

    • Aerospan

    • Flovent

    • Others



  • Anticholinergics

    • Spiriva

    • Others



  • Short Acting Beta Agonists(SABA)

    • ProAir

    • Ventolin

    • Others



  • Long Acting Beta Agonists (LABA)

  • Others



MARKET BY GEOGRAPHY




  • North America


    • U.S.

    • Canada

    • Mexico



  • Europe

    • U.K.

    • France

    • Germany

    • Italy

    • Rest of Europe

    • Asia-Pacific

    • Japan

    • China

    • India



  • Rest of Asia-Pacific

    • LAMEA

    • Latin America

    • Middle East

    • Africa





KEY PLAYERS




  • GlaxoSmithKline (GSK)

  • Novartis AG.

  • Merck & Co.

  • Abbott Laboratories.

  • Boehringer Ingelheim.

  • AstraZeneca.

  • Roche Holding AG

  • Teva Pharmaceutical Industries.

  • Vectura Group

  • Pfizer



Other players in the value chain include (profiles not included in the report)




  • Mylan

  • Aerovance Inc.

  • Alkermes Inc.

  • Almirall SA

  • Genentech Inc.

  • Sepracor, Inc.

  • Skyepharma plc


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Paclitaxel Injection Market (Treatment of Cancer and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Paclitaxel belongs to the group of medications known as antineoplastics and is used in the treatment of cancers. It works by inhibiting the growth of cancer cells and is used ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market (Types, Drugs and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Acute Lymphocytic/Lymphoblastic leukemia is a kind of blood or bone marrow cancer. It occurs in lymphocytes which are white blood cells. It can then easily spread to the other parts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Veterinary/Animal Vaccines Market - Opportunities and Forecasts, 2015 - 2020

Veterinary/animal vaccines are injected to animals to improve health conditions, increase production of livestock in economical way and prevent transmission of infectious diseases. These vaccines provide immunity against bacterial, viral, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Pharmaceutical Excipients Market - Opportunities and Forecasts, 2015 - 2020

Pharmaceuticals excipient is a substance added with an active ingredient during manufacturing process of a drug. It helps in long term stabilization, reduction of viscosity, and enhancement of solubility of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemoglobinopathies Market (Pipeline Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>